N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide
C19H28N4O3 — CID 155871661
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide
N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide (PubChem CID 155871661) has the molecular formula C19H28N4O3 and a molecular weight of 360.46 g/mol. Its IUPAC name is N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide.
Molecular Properties
| Compound Name | N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide |
|---|---|
| PubChem CID | 155871661 |
| Molecular Formula | C19H28N4O3 |
| Molecular Weight | 360.46 g/mol |
| Exact Mass | 360.22 |
| IUPAC Name | N-cyclopentyl-1-(4-hydroxypiperidine-1-carbonyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine-6-carboxamide |
| SMILES | O=C(NC1CCCC1)C1CCc2c(C(=O)N3CCC(O)CC3)ncn2C1 |
| InChI | InChI=1S/C19H28N4O3/c24-15-7-9-22(10-8-15)19(26)17-16-6-5-13(11-23(16)12-20-17)18(25)21-14-3-1-2-4-14/h12-15,24H,1-11H2,(H,21,25) |
| InChIKey | AFRMXOFCLCDRCR-UHFFFAOYSA-N |
| XLogP | 1.10 |
| TPSA | 87.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 360.46 |
| LogP ≤ 5 | 1.10 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155871661 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.